Technical Analysis for SMMT - Summit Therapeutics plc

Grade Last Price % Change Price Change
grade D 1.42 -5.33% -0.08
SMMT closed down 5.33 percent on Friday, January 18, 2019, on 7 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical SMMT trend table...

Date Alert Name Type % Chg
Jan 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jan 18 Inside Day Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Hammer Candlestick Bullish -5.33%
Jan 17 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.33%
Jan 17 Doji - Bullish? Reversal -5.33%
Jan 17 Wide Bands Range Expansion -5.33%
Jan 16 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.05%
Jan 16 Narrow Range Bar Range Contraction -4.05%
Jan 16 NR7 Range Contraction -4.05%

Older signals for SMMT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Summit Corporation plc, a drug discovery and development company, engages in the discovery and development of novel drug candidates to treat areas of high unmet medical need. The company licenses its drug discovery platform, known as Seglin technology, for the identification of new drug leads and candidates with the potential to target a range of diseases. Its pipeline consists of clinical stage programmes targeting Duchenne Muscular Dystrophy (DMD) and Clostridium difficile infection (CDI). The company provides SMT C1100, a small molecule Utrophin modulator for DMD patients that has completed Phase I clinical trial; and SMT 19969, a Phase I clinical trial completed novel molecule antibiotic for the treatment for initial CDI and prevention of recurrent disease. It is also engaged in other programmes that include OGA inhibitor programme for the treatment of dementia. The company has a technology license agreement with Bristol-Myers Squibb to access the Seglin technology platform. It has operations primarily in the United Kingdom and the United States. The company was formerly known as VASTox plc and changed its name to Summit Corporation Plc in July 2007. Summit Corporation plc was founded in 2003 and is headquartered in Abingdon, the United Kingdom.
Is SMMT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.9
52 Week Low 1.1
Average Volume 33,036
200-Day Moving Average 5.2737
50-Day Moving Average 1.3552
20-Day Moving Average 1.376
10-Day Moving Average 1.528
Average True Range 0.1141
ADX 27.39
+DI 17.9816
-DI 12.2443
Chandelier Exit (Long, 3 ATRs ) 1.3277
Chandelier Exit (Short, 3 ATRs ) 1.4423
Upper Bollinger Band 1.7119
Lower Bollinger Band 1.0401
Percent B (%b) 0.57
BandWidth 48.822674
MACD Line 0.0455
MACD Signal Line 0.0356
MACD Histogram 0.0099
Fundamentals Value
Market Cap 17.59 Million
Num Shares 12.4 Million
EPS -0.36
Price-to-Earnings (P/E) Ratio -3.94
Price-to-Sales 4.01
Price-to-Book 26.16
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.51
Resistance 3 (R3) 1.52 1.50 1.50
Resistance 2 (R2) 1.50 1.48 1.50 1.49
Resistance 1 (R1) 1.46 1.46 1.45 1.45 1.48
Pivot Point 1.44 1.44 1.44 1.44 1.44
Support 1 (S1) 1.40 1.42 1.39 1.39 1.36
Support 2 (S2) 1.38 1.40 1.38 1.35
Support 3 (S3) 1.34 1.38 1.35
Support 4 (S4) 1.33